ADVAXIS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ADVAXIS and buy or sell other stocks, ETFs, and their options commission-free!

About ADXS

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. 

CEO
Ken Berlin
CEOKen Berlin
Employees
15
Employees15
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1987
Founded1987
Employees
15
Employees15

ADXS Key Statistics

Market cap
112.87K
Market cap112.87K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
3.94K
Average volume3.94K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$51.60
52 Week high$51.60
52 Week low
$1.02
52 Week low$1.02

People also own

Based on the portfolios of people who own ADXS. This list is generated using Robinhood data, and it’s not a recommendation.
Zomedica
Tonix Pharmaceuticals
Castor Maritime
Sundial Growers
Acasti Pharma
Northern Dynasty Minerals
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.